Cadrenal Therapeutics Ownership | Who Owns Cadrenal Therapeutics?

Cadrenal Therapeutics Ownership Summary

Cadrenal Therapeutics is owned by 3.78% institutional investors, 16.99% insiders, and 79.23% retail investors. Geode capital management is the largest institutional shareholder, holding 0.90% of CVKD shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.08% of its assets in Cadrenal Therapeutics shares.

CVKD Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Cadrenal Therapeutics	3.78%	16.99%	79.23%
Sector	Healthcare Stocks	35.58%	11.87%	52.55%
Industry	Biotech Stocks	35.75%	11.83%	52.41%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Geode capital management	21.63K	0.90%	$110.72K
Vanguard fiduciary trust	8.31K	0.35%	$42.55K
Jpmorgan chase	7.50K	0.31%	$31.88K
Blackrock funding, inc. /de	5.50K	0.23%	$28.14K
Tower research capital llc (trc)	393.00	0.02%	$2.01K
Advisor group	300.00	0.01%	$1.54K
Destiny wealth partners	200.00	0.01%	$1.02K
Rockefeller capital management	150.00	0.01%	$768.00
Morgan stanley	100.00	0.00%	$512.00
Wells fargo & company/mn	99.00	0.00%	$507.00

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Destiny wealth partners	200.00	0.00%	$1.02K
Tower research capital llc (trc)	393.00	0.00%	$2.01K
Drw securities	-	-	-
Ifp advisors	30.00	-	$154.00
Advisor group	300.00	-	$1.54K
Harbour investments	-	-	-
Archer investment	35.00	-	$179.00
Jpmorgan chase	7.50K	-	$31.88K
Lpl financial	-	-	-
Ubs group	3.00	-	$15.00

Top Buyers

Holder	Shares	% Assets	Change
Vanguard fiduciary trust	8.31K	-	8.31K
Geode capital management	21.63K	-	7.10K
Blackrock funding, inc. /de	5.50K	-	1.97K
Destiny wealth partners	200.00	0.00%	200.00
Citigroup	1.00	-	1.00

Top Sellers

Holder	Shares	% Assets	Change
Drw securities	-	-	-25.15K
Lpl financial	-	-	-13.00K
Ubs group	3.00	-	-1.04K
Morgan stanley	100.00	-	-980.00
Advisor group	300.00	-	-200.00

New Positions

Holder	Shares	% Assets	Change	Value
Vanguard fiduciary trust	8.31K	-	8.31K	$42.55K
Destiny wealth partners	200.00	0.00%	200.00	$1.02K
Citigroup	1.00	-	1.00	$5.00

Sold Out

Holder	Change
Harbour investments	-100.00
Clearstead advisors	-150.00
Lpl financial	-13.00K
Drw securities	-25.15K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	17	-5.56%	90,938	-25.15%	3	10.17%	7	-	5	150.00%
Dec 31, 2025	18	5.88%	121,486	6.39%	6	19.52%	7	-12.50%	2	-33.33%
Sep 30, 2025	17	21.43%	114,193	67.08%	5	46.02%	8	14.29%	3	-
Jun 30, 2025	14	7.69%	68,347	-1.38%	3	24.67%	7	-36.36%	3	200.00%
Mar 31, 2025	13	44.44%	69,304	366.85%	3	396.62%	11	22.22%	1	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	33.28K	1.08%	-
Fidelity Extended Market Index	14.70K	0.48%	3.98K
Vanguard Institutional Extnd Mkt Idx Tr	11.92K	0.39%	-
Abante Quant Value FI	6.88K	0.22%	-
iShares Micro-Cap ETF	5.30K	0.17%	-
Fidelity Series Total Market Index	2.45K	0.08%	600.00
Spartan Extended Market Index Pool F	2.25K	0.07%	47.00
NT Ext Equity Mkt Index Fund - NL	1.55K	0.05%	-
NT Ext Equity Mkt Index Fund - Lending	1.32K	0.04%	-
Northern Trust Extended Eq Market Idx	1.32K	0.04%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jun 10, 2026	Pham Quang X	Chairman, CEO and Interim CFO	Sell	$14.73K
Jun 08, 2026	Pham Quang X	Chairman, CEO and Interim CFO	Sell	$25.81K
Jun 09, 2026	Pham Quang X	Chairman, CEO and Interim CFO	Sell	$52.75K
Jun 03, 2026	Pham Quang X	CEO and Chairman	Sell	$9.90K
Jun 04, 2026	Pham Quang X	CEO and Chairman	Sell	$17.19K

Insider Transactions Trends

Date	Buy	Sell
2026 Q2	-	12
2025 Q4	-	13
2025 Q3	-	10
2025 Q1	-	-
2024 Q2	-	-

CVKD Ownership FAQ

Who Owns Cadrenal Therapeutics?

Cadrenal Therapeutics shareholders are primarily institutional investors at 3.78%, followed by 16.99% insiders and 79.23% retail investors. The average institutional ownership in Cadrenal Therapeutics's industry, Biotech Stocks , is 35.75%, which Cadrenal Therapeutics falls below.

Who owns the most shares of Cadrenal Therapeutics?

Cadrenal Therapeutics’s largest shareholders are Geode capital management (21.63K shares, 0.90%), Vanguard fiduciary trust (8.31K shares, 0.35%), and Jpmorgan chase (7.5K shares, 0.31%). Together, they hold 1.55% of Cadrenal Therapeutics’s total shares outstanding.

Does Blackrock own Cadrenal Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Cadrenal Therapeutics.

Who is Cadrenal Therapeutics’s biggest shareholder by percentage of total assets invested?

Destiny wealth partners is Cadrenal Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.00% of its assets in 200 Cadrenal Therapeutics shares, valued at 1.02K$.

Who is the top mutual fund holder of Cadrenal Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Cadrenal Therapeutics shares, with 1.08% of its total shares outstanding invested in 33.28K Cadrenal Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools